PeriNomS
This study has completed.
PATH extension study
This study is completed.
FORCIDP
We are recruiting to a trial of the novel agent Fingolimod for the treatment of CIDP.
There are several other studies currently under development.
For all enquiries, please contact Professor Mike Lunn on 02034488121.